Albach, F. N., Geier, C., Keicher, C., Posch, M. G., Schreiber, S. J., Grütz, G., . . . Wagner, F. Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationAlbach, Fredrik N., et al. Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis. Adis, Springer Healthcare.
MLA (9th ed.) CitationAlbach, Fredrik N., et al. Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis. Adis, Springer Healthcare.
Warning: These citations may not always be 100% accurate.